Somite is a Biotech company based in Boston. It has raised $47M in total funding. Latest round: Series A.
Somite funding overview
Somite is a Biotech company based in Boston. Somite has raised $47M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in May 2025. The round record for Somite runs through 2025; nothing later has been disclosed. Investors on record include Khosla Ventures, Chan Zuckerberg Initiative, Fusion Fund. 3 distinct backers are named across the disclosed rounds.
Somite at a glance
Total raised
$47M
Latest round
Series A
Latest round date
May 2025
Industry
Biotech
Headquarters
Boston
Notable investors
Khosla Ventures, Chan Zuckerberg Initiative, Fusion Fund
Frequently asked about Somite funding
How much has Somite raised?
Somite has raised $47M in total disclosed funding across the rounds on record.
Who has invested in Somite?
Khosla Ventures, Chan Zuckerberg Initiative, Fusion Fund are named among the investors backing Somite.
What was the latest Somite funding round?
The most recent disclosed round is a Series A, announced in May 2025.
Where is Somite based?
Somite is based in Boston.
What sector does Somite operate in?
Somite is tracked under Biotech from Boston, with $47M in disclosed funding.
When did Somite last raise?
The last disclosed Somite round closed in May 2025 at Series A.
Totals shown for Somite aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Boston and the investors behind them below.
